ED80 - Acne: Complete ICD-11 Coding Guide

1. Introduction

Acne is one of the most prevalent dermatological conditions worldwide, affecting mainly adolescents and young adults, although it can persist or emerge at any age. Characterized by inflammation of the pilosebaceous units, acne manifests through comedones, papules, pustules, nodules, and in more severe cases, cysts that can leave permanent scars.

The clinical importance of acne transcends its physical manifestations. Studies demonstrate that this condition has a significant impact on quality of life, self-esteem, and mental health of patients, and may be associated with anxiety and depression. Psychosocial impairment is frequently disproportionate to apparent clinical severity, making a comprehensive and patient-sensitive approach essential.

From a public health perspective, acne represents a frequent reason for dermatological consultations and primary care visits. Its high prevalence generates considerable demand for medical services, topical and systemic medications, as well as specialized procedures. Appropriate management prevents complications such as permanent scars and post-inflammatory hyperpigmentation, which can be difficult to treat.

Correct coding using ICD-11 is fundamental for various aspects of modern medical practice. It enables accurate epidemiological recording, facilitating prevalence and incidence studies, aids in public health resource planning, ensures appropriate reimbursement by insurance companies, enables traceability of the patient's clinical history, and contributes to clinical research and development of new therapeutics. The code ED80 specifically refers to acne without additional specifications, serving as a general category within the spectrum of acneiform diseases.

2. Correct ICD-11 Code

Code: ED80

Description: Acne

Parent category: null - Acne and related diseases

Official definition: Acne without further specification.

The code ED80 in the ICD-11 classification system represents the general category for acne when there is no additional specification about the type, severity, or particular characteristics of the condition. This code belongs to the chapter of dermatological diseases and is inserted in the grouping of acneiform conditions, which share pathophysiological characteristics related to sebaceous glands and hair follicles.

The hierarchical structure of ICD-11 allows the code ED80 to function as a main category, from which more specific subcategories are derived. This organization facilitates both general coding and detailed specification when additional information is available. The use of this code is appropriate when the diagnosis of acne is established, but there is insufficient information or no need to specify particular subtypes.

The transition to ICD-11 brought greater clarity in the classification of acneiform conditions, separating them from other dermatoses that previously could generate diagnostic confusion. ED80 serves as a starting point for adequate clinical documentation, and can be complemented with additional codes when specific characteristics need to be recorded, such as severity, atypical location, or associated complications.

3. When to Use This Code

The ED80 code should be used in specific clinical scenarios where the diagnosis of acne is confirmed, but there is no need or possibility for further specification. Below, we present detailed practical situations:

Scenario 1: Unspecified Acne Vulgaris in Adolescent

A 16-year-old patient presents with characteristic acne lesions on the face, including open and closed comedones, papules, and some pustules distributed in the frontal, malar, and mental regions. The condition has lasted approximately one year, with variable intensity. There are no features suggesting special forms of acne or significant complications. In this case, ED80 is appropriate as it represents typical acne without additional specifications needed.

Scenario 2: First Consultation with Limited Information

During care at a primary care service, the patient reports a history of acne and requests therapeutic guidance. Physical examination confirms the presence of active acneiform lesions, but the consultation time or available resources do not allow for detailed classification regarding severity or specific subtype. The ED80 code allows adequate documentation of the diagnosis while initial treatment is established.

Scenario 3: Acne in Young Adult without Special Features

A 25-year-old patient presents with persistent facial acne since adolescence, without recent worsening or atypical features. The lesions are predominantly comedonal with some mild inflammatory lesions. There are no signs of nodular, conglobata, or fulminant acne. No specific triggering factors were identified such as medication use or occupational exposure. ED80 adequately codes this case of common acne without particularities.

Scenario 4: Follow-up of Previously Diagnosed Acne

The patient returns for follow-up consultation for acne diagnosed previously. The condition is stable, without significant changes that would justify reclassification or additional specification. The ED80 code maintains continuity of the diagnostic record without need for changes.

Scenario 5: Mild to Moderate Acne in Outpatient Record

During dermatological screening, a patient with mild to moderate intensity acne is identified, with non-inflammatory and inflammatory lesions distributed classically. There is no indication of severe forms or specific variants that require differentiated coding. ED80 captures the essential diagnosis for purposes of record-keeping and therapeutic planning.

Scenario 6: Acne without Associated Dermatological Comorbidities

The patient presents with isolated acne, without association with other dermatological conditions such as rosacea, seborrheic dermatitis, or bacterial folliculitis. The lesions are typical of acne vulgaris, without need for differentiation of secondary or induced acneiform conditions. The ED80 code is sufficient to document the primary diagnosis.

4. When NOT to Use This Code

It is fundamental to recognize situations where code ED80 is not appropriate, requiring more specific or alternative codes:

Specific Acneiform Conditions

ED80 should not be used when there is a diagnosis of specific acne variants that have their own codes. Acne conglobata, acne fulminans, neonatal acne, and infantile acne require specific coding within the system's subcategories. These forms present distinct clinical characteristics, different prognosis, and particular therapeutic approaches that justify their separation from the general code.

Acneiform Inflammatory Diseases

Conditions that mimic acne but have different etiology should be coded as ED81 (Acneiform inflammatory diseases). This includes acneiform eruptions induced by medications such as corticosteroids, lithium, isoniazid, or exogenous androgens. It also encompasses occupational acne caused by exposure to mineral oils, tar, or halogenated compounds. Rosacea, although it may present with papules and pustules, has distinct pathophysiology and should not be coded as ED80.

Folliculitis and Other Papulopustular Dermatoses

Bacterial, fungal, or Malassezia folliculitis present lesions that may be confused with acne, but require specific codes for cutaneous infections. Pseudofolliculitis barbae, common in individuals with curly hair, should also not be coded as acne.

Acne with Significant Complications

When acne results in extensive scarring, keloids, or severe post-inflammatory hyperpigmentation that becomes the primary problem, additional or alternative codes may be necessary to adequately capture the patient's current condition.

Underlying Endocrine Conditions

When acne is a secondary manifestation of polycystic ovary syndrome, congenital adrenal hyperplasia, or other endocrinopathies, the primary code should reflect the underlying condition, with ED80 being used as a secondary diagnosis if appropriate.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The diagnosis of acne is primarily clinical, based on the identification of characteristic lesions in areas with the highest density of sebaceous glands. The examiner must identify the presence of comedones (open or closed), which are pathognomonic for acne, differentiating it from other papulopustular conditions. Typical distribution includes the face, neck, anterior chest, and upper back.

The history should investigate age of onset, symptom duration, aggravating or alleviating factors, previous treatments, and impact on quality of life. Detailed physical examination documents the types of lesions present: non-inflammatory comedones (blackheads and whiteheads), inflammatory papules and pustules, nodules and cysts in more severe cases. Assessment of the extent and distribution of lesions complements the diagnosis.

Although rarely necessary, complementary tests may be requested in specific situations. Bacterial culture can be useful in treatment-resistant cases to identify antimicrobial resistance. Hormonal evaluation is indicated when there are signs of hyperandrogenism, menstrual irregularity, or sudden onset in adults. Skin biopsy is reserved for atypical cases where diagnostic doubt exists.

Step 2: Verify Specifiers

After confirming the diagnosis of acne, evaluate whether there are characteristics that require additional specification. Severity can be classified as mild (predominance of comedones with few inflammatory lesions), moderate (greater number of papules and pustules), or severe (presence of nodules and cysts). If severity is a critical element for therapeutic planning or prognosis, consider whether a specific code is available.

Verify the duration of the condition: acute acne with recent onset may have different implications than persistent chronic acne. Identify possible triggering factors such as use of comedogenic cosmetics, medications, occupational exposure, or excessive manipulation of lesions.

Evaluate special characteristics such as atypical distribution (acne predominantly affecting the trunk or unusual areas), presence of significant scarring, or association with signs of hyperandrogenism. If these characteristics constitute specific acne variants, more specific codes may be necessary instead of ED80.

Step 3: Differentiate from Other Codes

The main differentiation within the category of acne and related diseases is with code ED81 - Acneiform inflammatory diseases. The fundamental distinction is that ED80 represents true acne, where there is primary dysfunction of the pilosebaceous unit with excessive sebum production, follicular hyperkeratinization, and colonization by Cutibacterium acnes.

On the other hand, ED81 encompasses conditions that present lesions similar to acne but have different etiology, such as drug-induced acneiform eruptions, occupational acne from exposure to specific substances, or other dermatoses that mimic acne. If there is a clear history of exposure to medications or chemical substances preceding the appearance of acneiform lesions, consider ED81.

Other important differentiations include separating acne from rosacea (which presents persistent facial erythema, telangiectasias, and absence of comedones), bacterial folliculitis (more uniform lesions, usually pustular, without comedones), and perioral dermatitis (characteristic distribution around the mouth, sparing the vermillion border).

Step 4: Required Documentation

Adequate documentation to justify code ED80 should include:

Checklist of Mandatory Information:

Description of types of lesions present (comedones, papules, pustules, nodules)
Anatomical location of lesions
Approximate duration of the condition
Previous treatments performed and their responses
Exclusion of secondary causes (medications, occupational exposures)
Assessment of impact on quality of life when relevant

Appropriate Record: The medical record should contain objective description such as: "Patient presents with facial acne with open and closed comedones, erythematous papules and pustules distributed in the frontal region, bilateral malar area, and chin. Condition with approximately 18 months of evolution. Denies use of potentially causative medications. Previous treatment with topical benzoyl peroxide with partial response."

This documentation allows other professionals to understand the diagnosis, justifies the coding choice for administrative and research purposes, and establishes a baseline to evaluate future therapeutic response.

6. Complete Practical Example

Clinical Case

A 17-year-old female patient, student, presents to dermatology consultation accompanied by her mother, complaining of "pimples on the face" for approximately two years. She reports that the condition started at age 15 with progressive onset of facial lesions that cause social embarrassment, especially in the school environment. She reports worsening premenstrually and after consumption of fatty foods, although she is uncertain about this association.

On dermatological physical examination, multiple open comedones (blackheads) and closed comedones (whiteheads) are observed distributed in the frontal region, nose, and chin. Also present are approximately 15-20 erythematous papules of 2-4mm and about 8 pustules in bilateral malar region and chin. There are no nodules or cysts. Some residual hyperchromic macules from previous lesions are observed, without significant atrophic or hypertrophic scarring. The remainder of the skin shows no relevant alterations.

The patient denies use of continuous medications, does not use hormonal contraceptives, and reports regular menstrual cycles. She denies symptoms of hyperandrogenism such as hirsutism or excessive hair loss. She has previously used acne-specific soaps purchased without prescription, with mild and temporary improvement. She has not undergone previous dermatological treatment.

The patient's mother reports having had acne during adolescence with spontaneous resolution in the third decade of life. The patient demonstrates anxiety regarding appearance and reports avoiding social situations due to facial lesions.

Step-by-Step Coding

Criteria Analysis:

Diagnostic confirmation: Presence of pathognomonic lesions (comedones) associated with inflammatory lesions (papules and pustules) in typical acne distribution (face, seborrheic areas).
Exclusion of differential diagnoses: Absence of history of acneigenic medication use, no occupational exposure, no characteristics of rosacea (absence of diffuse facial erythema and telangiectasias), no signs of folliculitis (lesions are polymorphic, not uniformly pustulous).
Evaluation of specifiers: Acne of mild to moderate severity, without characteristics that constitute specific variants such as acne conglobata, fulminans, or neonatal acne. There are no significant complications such as extensive scarring.
Verification of secondary causes: Clinical history and physical examination do not suggest underlying endocrinopathy. Regular menstrual cycles, absence of hirsutism or other signs of hyperandrogenism.

Code Selected: ED80 - Acne

Complete Justification:

The code ED80 is appropriate for this case as it is typical acne vulgaris without additional specifications needed. The patient presents with classic acne presentation in an adolescent, with characteristic lesions (comedones, papules, and pustules) in typical distribution, without complicating factors or characteristics requiring more specific coding.

There is no indication for use of ED81 (Acneiform inflammatory diseases) as this is not a secondary acneiform eruption due to medications or occupational exposure. Specific subcategories of acne also do not apply, as there are no characteristics of severe forms or special variants.

Complementary Codes:

There is no need for additional codes in this specific case. If there were significant scarring or extensive post-inflammatory hyperpigmentation as the chief complaint, additional codes could be considered to document these complications.

Documented Therapeutic Plan:

Initiated topical treatment with retinoid and benzoyl peroxide, guidance on skin care and clarification of misconceptions about diet and acne. Follow-up scheduled in 8-12 weeks to evaluate therapeutic response.

7. Related Codes and Differentiation

Within the Same Category

ED81: Acneiform Inflammatory Diseases

The distinction between ED80 and ED81 is fundamental for accurate coding. ED80 represents true acne, where there is a primary process of pilosebaceous unit dysfunction. ED81 encompasses conditions that present with lesions clinically similar to acne, but have a distinct etiology.

When to use ED81 instead of ED80:

Acneiform eruption induced by systemic or potent topical corticosteroids
Drug-induced acne from lithium, phenytoin, isoniazid, or B-complex vitamins in high doses
Occupational acne from exposure to mineral oils, petroleum derivatives, or halogenated compounds
Acneiform eruptions from anabolic steroids
Cosmetic acne from use of comedogenic products

Main difference: Clinical history is the key differentiating element. In ED81, there is a clear temporal relationship between exposure to a specific agent and the onset of lesions, whereas in ED80 there is no identifiable external causal factor, representing an endogenous process of the sebaceous gland.

Differential Diagnoses

Rosacea: Presents with persistent facial erythema, telangiectasias, papules and pustules, but characteristically does not present with comedones. Predominantly affects middle-aged adults, with central distribution on the face.

Bacterial Folliculitis: More uniform lesions, predominantly pustular, frequently pruritic, without comedones. May affect areas with terminal hair such as scalp, beard, and gluteal region.

Perioral Dermatitis: Papules and pustules grouped around the mouth, sparing the margin of the lip vermillion. Frequently associated with the use of topical facial corticosteroids.

Acneiform Eruption from EGFR Inhibitors: In oncology patients using targeted therapies such as cetuximab or erlotinib, papulopustular lesions emerge that mimic acne, but have a specific clinical context.

8. Differences with ICD-10

In the ICD-10 classification system, acne was coded primarily as L70 - Acne, with subdivisions such as L70.0 (Acne vulgaris), L70.1 (Acne conglobata), L70.2 (Acne varioliformis), among others. The generic code for unspecified acne was L70.9.

Main Changes in ICD-11:

The transition to ICD-11 brought significant structural reorganization. The code changed from L70.9 to ED80, reflecting a new categorization architecture. ICD-11 adopted a more hierarchical and flexible structure, allowing better specification through extensions and qualifiers when necessary, rather than relying exclusively on fixed subcategories.

The terminology was updated to reflect contemporary scientific knowledge. The separation between true acne (ED80) and acneiform inflammatory diseases (ED81) is clearer in ICD-11, facilitating differentiation of conditions that previously could have been grouped ambiguously.

Practical Impact:

For health information systems, migration requires updating databases and training professionals responsible for coding. Longitudinal epidemiological studies need to establish correspondence between old and new codes to maintain historical continuity.

In daily clinical practice, the change is relatively transparent, as the clinical diagnosis remains unchanged. However, professionals must familiarize themselves with the new structure to ensure accurate coding, especially in documents that require specific ICD-11 codes, such as reports for insurance companies or clinical research records.

ICD-11 offers advantages such as better compatibility with electronic health systems, greater granularity when needed, and alignment with contemporary clinical terminologies, facilitating health information exchange globally.

9. Frequently Asked Questions

1. How is the diagnosis of acne that justifies the ED80 code made?

The diagnosis is essentially clinical, based on the identification of characteristic lesions during dermatological physical examination. The physician looks for comedones (open or closed), which are pathognomonic lesions of acne, associated or not with inflammatory lesions such as papules, pustules, nodules, or cysts. The typical distribution in seborrheic areas (face, upper chest, back) reinforces the diagnosis. The history complements the investigation by exploring duration, aggravating factors, previous treatments, and impact on quality of life. Laboratory tests are generally not necessary for the diagnosis of common acne, being reserved for cases with suspected associated endocrinopathies or atypical forms.

2. Is treatment available in public health systems?

Yes, acne treatments are widely available in public health systems in various countries. Basic therapeutic options include topical medications such as benzoyl peroxide, retinoids, and antibiotics, as well as oral antibiotics for moderate to severe cases. Many of these medications are included in lists of essential medicines. More specialized treatments, such as oral isotretinoin for severe cases, may have specific prescription and monitoring protocols. The exact availability varies according to the local health system, but the recognition of acne as a legitimate medical condition ensures access to basic treatment in most contexts.

3. How long does acne treatment last?

Treatment duration varies according to severity and individual response. Topical treatments generally require continuous use for at least 8-12 weeks before assessing complete efficacy, as the skin renewal cycle and inflammatory response require time. Mild to moderate cases may require treatment for several months until adequate control is achieved. Oral antibiotics, when indicated, are typically prescribed for 3-6 months. Oral isotretinoin for severe cases has a usual duration of 4-6 months. It is important to note that acne is frequently a chronic condition, potentially requiring prolonged maintenance therapy to prevent recurrences, especially in adults. Regular medical follow-up allows therapeutic adjustments according to disease progression.

4. Can this code be used in medical certificates?

Yes, the ED80 code can be used in medical certificates when appropriate. Although acne is not typically a cause of prolonged work or school absence, specific situations may justify medical documentation, such as dermatological procedures that cause temporary discomfort, initial adverse reactions to medications, or documented significant psychological impact. The ICD code provides international standardization that facilitates understanding of the diagnosis by different institutions. In certificates, it is recommended to include not only the code, but also a brief description that contextualizes the need for absence when applicable, always respecting patient privacy and dignity.

5. Should acne in adults be coded differently from acne in adolescents?

The ED80 code is appropriate for both adolescents and adults when it comes to acne without additional specifications. The patient's age does not determine a different code, unless there are specific characteristics that constitute particular variants. Neonatal or infantile acne has specific coding as it represents distinct pathophysiological entities. However, acne vulgaris in a 30-year-old adult and in a 15-year-old adolescent, without special characteristics, both receive the ED80 code. Clinically, it may be relevant to document the age of onset and context (acne persistent since adolescence versus late-onset acne in an adult), as this may influence investigation of secondary causes, but it does not alter the basic coding.

6. Is it necessary to specify the severity of acne when using the ED80 code?

The ED80 code itself does not include severity specification. If severity classification is clinically relevant for therapeutic planning, prognosis, or research, it should be documented in the clinical description in the medical record, but not necessarily through a separate code, unless the local system uses extensions or additional qualifiers allowed by the ICD-11 structure. In clinical practice, it is always recommended to document severity (mild, moderate, severe) in the narrative description, as this guides therapeutic decisions and allows monitoring of disease progression, even if not directly reflected in the primary code.

7. When should I consider additional investigation beyond clinical diagnosis of acne?

Additional investigation is indicated in specific situations: sudden-onset acne in an adult, especially if accompanied by signs of hyperandrogenism (hirsutism, menstrual irregularity, androgenetic alopecia); severe acne refractory to conventional treatments; presence of systemic signs suggesting endocrinopathy; or atypical characteristics that raise diagnostic doubt. In these cases, hormonal evaluation (testosterone, DHEA-S, LH, FSH) may be appropriate. Bacterial culture is considered in treatment-resistant cases to assess antimicrobial resistance. Most cases of common acne in adolescents and young adults do not require laboratory investigation, with diagnosis and treatment based exclusively on clinical evaluation.

8. Does the ED80 code remain valid if the patient develops acne scars?

Yes, the ED80 code remains appropriate for documenting active acne. If scars become a significant clinical problem, an additional specific code for scars can be included to capture this complication separately. The presence of scars does not invalidate the diagnosis of acne; in fact, it confirms a history of inflammatory process. In consultations where the main focus is treatment of residual scars in a patient with controlled acne, the prioritization of codes may reflect the current therapeutic objective, but both conditions can be documented. Coding should reflect the complete clinical picture and the problems being actively addressed in the specific consultation.

Conclusion

Appropriate coding of acne using the ED80 code from ICD-11 is essential for accurate clinical documentation, public health planning, and epidemiological research. Understanding when to use this general code versus more specific codes ensures appropriate recording that benefits both individual patient care and health systems at the population level. The transition from ICD-10 to ICD-11 brought structural improvements that facilitate more precise classification of dermatological conditions while maintaining compatibility with established clinical practices.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Acne

Compartir